The University of Southampton
University of Southampton Institutional Repository

Deubiquitylase inhibition reveals liver X receptor-independent transcriptional regulation of the E3 ubiquitin ligase IDOL and lipoprotein uptake

Deubiquitylase inhibition reveals liver X receptor-independent transcriptional regulation of the E3 ubiquitin ligase IDOL and lipoprotein uptake
Deubiquitylase inhibition reveals liver X receptor-independent transcriptional regulation of the E3 ubiquitin ligase IDOL and lipoprotein uptake

Cholesterol metabolism is subject to complex transcriptional and nontranscriptional regulation. Herein, the role of ubiquitylation is emerging as an important post-translational modification that regulates cholesterol synthesis and uptake. Similar to other post-translational modifications, ubiquitylation is reversible in a process dependent on activity of deubiquitylating enzymes (DUBs). Yet whether these play a role in cholesterol metabolism is largely unknown. As a first step to test this possibility, we used pharmacological inhibition of cellular DUB activity. Short term (2 h) inhibition of DUBs resulted in accumulation of high molecular weight ubiquitylated proteins. This was accompanied by a dramatic decrease in abundance of the LDLR and attenuated LDL uptake into hepatic cells. Importantly, this occurred in the absence of changes in the mRNA levels of the LDLR or other SREBP2-regulated genes, in line with this phenotype being a post-transcriptional event. Mechanistically, we identify transcriptional induction of the E3 ubiquitin ligase IDOL in human and rodent cells as the underlying cause for ubiquitylation-dependent lysosomal degradation of the LDLR following DUB inhibition. In contrast to the established transcriptional regulation of IDOL by the sterol-responsive liver X receptor (LXR) transcription factors, induction of IDOL by DUB inhibition is LXR-independent and occurs in Lxrαβ(-/-) MEFs. Consistent with the role of DUBs in transcriptional regulation, we identified a 70-bp region in the proximal promoter of IDOL, distinct from that containing the LXR-responsive element, which mediates the response to DUB inhibition. In conclusion, we identify a sterol-independent mechanism to regulate IDOL expression and IDOL-mediated lipoprotein receptor degradation.

Absorption, Physiological/drug effects, Amino Acid Substitution, Animals, Cell Line, Cells, Cultured, Enzyme Inhibitors/pharmacology, Genes, Reporter, Human Umbilical Vein Endothelial Cells/cytology, Humans, Lipoproteins, LDL/metabolism, Liver X Receptors, Lysosomes/drug effects, Mice, Mutation, Orphan Nuclear Receptors/genetics, Promoter Regions, Genetic/drug effects, Proteolysis/drug effects, Receptors, LDL/genetics, Recombinant Fusion Proteins/chemistry, Recombinant Proteins/chemistry, Transcription, Genetic/drug effects, Ubiquitin-Protein Ligases/chemistry, Ubiquitin-Specific Proteases/antagonists & inhibitors, Ubiquitination/drug effects
1083-351X
4813-4825
Nelson, Jessica Kristine
7dc3f0c8-5a67-4467-a332-efd560a0630b
Cook, Emma Clare Laura
4a22ced7-83cf-4c33-b028-0fc258e2b78f
Loregger, Anke
35d8c1fe-e11e-481e-bd35-e8160c079231
Hoeksema, Marten Anne
07a02ea3-cc61-48ae-8501-ea9a721b7950
Scheij, Saskia
7863fcb2-eeba-43ab-93d5-8c9c08ad4289
Kovacevic, Igor
7c24bd0f-4942-4545-a5ef-51c7525d4039
Hordijk, Peter Lodewijk
50b5aedc-0c69-47d9-baea-9fe8614eb73f
Ovaa, Huib
5a942e60-1c49-4e8e-82cd-f71a98658ec0
Zelcer, Noam
c5eff664-b107-4a7c-9823-11ccb8149fbc
Nelson, Jessica Kristine
7dc3f0c8-5a67-4467-a332-efd560a0630b
Cook, Emma Clare Laura
4a22ced7-83cf-4c33-b028-0fc258e2b78f
Loregger, Anke
35d8c1fe-e11e-481e-bd35-e8160c079231
Hoeksema, Marten Anne
07a02ea3-cc61-48ae-8501-ea9a721b7950
Scheij, Saskia
7863fcb2-eeba-43ab-93d5-8c9c08ad4289
Kovacevic, Igor
7c24bd0f-4942-4545-a5ef-51c7525d4039
Hordijk, Peter Lodewijk
50b5aedc-0c69-47d9-baea-9fe8614eb73f
Ovaa, Huib
5a942e60-1c49-4e8e-82cd-f71a98658ec0
Zelcer, Noam
c5eff664-b107-4a7c-9823-11ccb8149fbc

Nelson, Jessica Kristine, Cook, Emma Clare Laura, Loregger, Anke, Hoeksema, Marten Anne, Scheij, Saskia, Kovacevic, Igor, Hordijk, Peter Lodewijk, Ovaa, Huib and Zelcer, Noam (2016) Deubiquitylase inhibition reveals liver X receptor-independent transcriptional regulation of the E3 ubiquitin ligase IDOL and lipoprotein uptake. The Journal of Biological Chemistry, 291 (9), 4813-4825. (doi:10.1074/jbc.M115.698688).

Record type: Article

Abstract

Cholesterol metabolism is subject to complex transcriptional and nontranscriptional regulation. Herein, the role of ubiquitylation is emerging as an important post-translational modification that regulates cholesterol synthesis and uptake. Similar to other post-translational modifications, ubiquitylation is reversible in a process dependent on activity of deubiquitylating enzymes (DUBs). Yet whether these play a role in cholesterol metabolism is largely unknown. As a first step to test this possibility, we used pharmacological inhibition of cellular DUB activity. Short term (2 h) inhibition of DUBs resulted in accumulation of high molecular weight ubiquitylated proteins. This was accompanied by a dramatic decrease in abundance of the LDLR and attenuated LDL uptake into hepatic cells. Importantly, this occurred in the absence of changes in the mRNA levels of the LDLR or other SREBP2-regulated genes, in line with this phenotype being a post-transcriptional event. Mechanistically, we identify transcriptional induction of the E3 ubiquitin ligase IDOL in human and rodent cells as the underlying cause for ubiquitylation-dependent lysosomal degradation of the LDLR following DUB inhibition. In contrast to the established transcriptional regulation of IDOL by the sterol-responsive liver X receptor (LXR) transcription factors, induction of IDOL by DUB inhibition is LXR-independent and occurs in Lxrαβ(-/-) MEFs. Consistent with the role of DUBs in transcriptional regulation, we identified a 70-bp region in the proximal promoter of IDOL, distinct from that containing the LXR-responsive element, which mediates the response to DUB inhibition. In conclusion, we identify a sterol-independent mechanism to regulate IDOL expression and IDOL-mediated lipoprotein receptor degradation.

Text
PIIS002192582043621X - Version of Record
Available under License Creative Commons Attribution.
Download (2MB)

More information

e-pub ahead of print date: 30 December 2015
Published date: 26 February 2016
Keywords: Absorption, Physiological/drug effects, Amino Acid Substitution, Animals, Cell Line, Cells, Cultured, Enzyme Inhibitors/pharmacology, Genes, Reporter, Human Umbilical Vein Endothelial Cells/cytology, Humans, Lipoproteins, LDL/metabolism, Liver X Receptors, Lysosomes/drug effects, Mice, Mutation, Orphan Nuclear Receptors/genetics, Promoter Regions, Genetic/drug effects, Proteolysis/drug effects, Receptors, LDL/genetics, Recombinant Fusion Proteins/chemistry, Recombinant Proteins/chemistry, Transcription, Genetic/drug effects, Ubiquitin-Protein Ligases/chemistry, Ubiquitin-Specific Proteases/antagonists & inhibitors, Ubiquitination/drug effects

Identifiers

Local EPrints ID: 505361
URI: http://eprints.soton.ac.uk/id/eprint/505361
ISSN: 1083-351X
PURE UUID: cf8a4685-a812-4064-814b-6377490a8f3f
ORCID for Jessica Kristine Nelson: ORCID iD orcid.org/0000-0003-2866-5170

Catalogue record

Date deposited: 07 Oct 2025 16:44
Last modified: 08 Oct 2025 02:17

Export record

Altmetrics

Contributors

Author: Jessica Kristine Nelson ORCID iD
Author: Emma Clare Laura Cook
Author: Anke Loregger
Author: Marten Anne Hoeksema
Author: Saskia Scheij
Author: Igor Kovacevic
Author: Peter Lodewijk Hordijk
Author: Huib Ovaa
Author: Noam Zelcer

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×